RhumbLine Advisers
YCBD icon

RhumbLine Advisers’s cbdMD YCBD Stock Holding History

RhumbLine Advisers’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-28
Closed -$10K – 3121
2020
Q1 		$10K Hold
28
– – ﹤0.01% 2920
2019
Q4 		$23K Buy
+28
New +$33.6K ﹤0.01% 2939

Other funds holding YCBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $99.5M AUM 25.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

RhumbLine Advisers's YCBD Position: Q2 2020 in Review

RhumbLine Advisers sold out of cbdMD (YCBD) in Q2 2020, closing a stake of 28 shares — an estimated $10K sold.

RhumbLine Advisers first reported a position in YCBD in Q4 2019 and held it in 2 quarters. The position peaked at $23K in Q4 2019. 48 funds tracked by Wall St. Rank hold YCBD as of Q2 2020.

  • RhumbLine Advisers reported no remaining cbdMD position as of Q2 2020 after selling out during the quarter.
  • RhumbLine Advisers sold 28 cbdMD shares in Q2 2020, an estimated $10K.
  • RhumbLine Advisers first reported a position in cbdMD in Q4 2019 and held it in 2 quarters.
  • RhumbLine Advisers's cbdMD position peaked at $23K in Q4 2019.
  • 48 funds tracked by Wall St. Rank held cbdMD as of Q2 2020.

Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.